Latest updates for Dimix

Fresh curated links around DIMIX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

fiercebiotech.com /1 month ago

Dimerix snaps up Mission’s stalled, phase 2-ready kidney disease candidate in $292M deal

Dimerix has bought an acute kidney injury drug from Mission Therapeutics, paying $5 million upfront and committing up to $287 million in milestones for the phase 2-ready asset.

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Dimix

fiercebiotech.com

Recent coverage from public sources
Public source